AXENIC CULTURE OF TETRATRICHOMONAS GALLINARUM: GROWTH AND ANAEROBIC UTILIZATION OF CARBOHYDRATES AND RELATED COMPOUNDS.

V. Theodorides

DOI: https://doi.org/10.1016/0014-4894(64)90034-7

IF: 2.132

1964-10-01

Experimental Parasitology

Abstract:

What problem does this paper attempt to address?

Ketogenic Dietary Therapy in Adult Status Epilepticus: Current Progress and Clinical Application

Cai Mengting,Xu Wanyin,Zheng Yang,Ding Meiping

DOI: https://doi.org/10.1186/s42494-022-00082-4

2022-01-01

Acta Epileptologica

Abstract:Status epilepticus (SE) is a common fatal neurological disease with high morbidity and mortality. Even if a large proportion of patients might be relieved from anti-seizure medications, sedatives and anesthetics, some still remain out of control. The ketogenic dietary (KD) has been proven useful in patients refractory to medications and/or who have failed to respond to surgical intervention. Recently, KD has shown beneficial therapeutic effects in children with SE, but studies in adults have rarely been reported. In this paper, we review the efficacy and utility of KD in adult SE patients and highlight its application for clinical reference and management.
The ketogenic diet for super-refractory status epilepticus patients in intensive care units

Eu Gene Park,Jiwon Lee,Jeehun Lee

DOI: https://doi.org/10.1016/j.braindev.2018.12.007

Abstract:Objectives: Super-refractory status epilepticus (SRSE) is one of the most challenging issues in intensive care units (ICUs) in that it is associated with high morbidity and mortality. Although the ketogenic diet (KD) has been reported to be effective in treating of SRSE, the use of the diet as therapy can be complicated by concomitant medical problems specific to critically ill patients. In this study, we aimed to describe our experience of the KD for SRSE patients in ICUs. Methods: We retrospectively reviewed the medical records of 16 patients (10 males, 6 females) with SRSE who were treated with the KD in the ICUs at Samsung Medical Center from July 2005 to July 2017. Results: The median age of seizure onset was 8 years (interquartile range 5-13.5). Prior to diet initiation, the patients were in convulsive or non-convulsive SRSE for a median of 23 days (range, 3-420). The median time to achieve ketosis was 3 days (range, 2-6). The KD was continued for a median of 2.1 months (range, 0.1-15.8). Of the 16 patients, nine (56.3%) achieved seizure freedom, six (37.5%) reported >50% seizure reduction, and one (6.2%) had <50% seizure improvement after the KD. There was no significant change in the number of antiepileptic drugs. The most commonly encountered complication during the KD was gastrointestinal disturbance. Conclusions: Our experience indicates that the KD is an effective alternative therapeutic strategy for SRSE patients in ICUs with adequate efficacy and safety in reducing seizure frequency and weaning from prolonged mechanical ventilation, although functional outcome was not favorable for most patients. Close monitoring and preventive management of potential adverse effects are critical elements for success with the KD in patients with SRSE.
Implementation Concerns of Scholar-Practitioners: A Pilot Study of the Link between Research and Practice

Claretha Hughes,Jai Wang,Wei Zheng,L. McLean

DOI: https://doi.org/10.4018/jabim.2010040104

2010-04-01

International Journal of Asian Business and Information Management

Abstract:The challenge of combining research and practice in HRD has led to continuing debate on who are scholar-practitioners and how they integrate research and practice in the workplace. This qualitative collective case study provides insights from seven scholar-practitioners to help HRD professionals and researchers understand implementation concerns of scholar-practitioners. The findings reveal scholar-practitionersâ€™ perceptions of their roles, the link between research and practice, and actions they took to overcome barriers and challenges related to integrating research and practice. This pilot study can serve as a benchmark for future studies regarding successful integration of research and practice in HRD.
Chinese expert recommendations on ketogenic diet therapy for super-refractory status epilepticus

Xin Tong,Qianyun Cai,Dezhi Cao,Lifei Yu,Dan Sun,Guang Yang,Jiwen Wang,Hua Li,Zengning Li,Juan Wang,Shaoping Huang,Meiping Ding,Fang Fang,Qun Wang,Rong Luo,Jianxiang Liao,Jiong Qin

DOI: https://doi.org/10.1186/s42494-021-00078-6

2022-01-01

Acta Epileptologica

Abstract:Super-refractory status epilepticus (SRSE) is a serious and life-threatening neurological condition. Ketogenic diet (KD) is a diet characterized by high fat, low carbohydrate, and moderate protein. As KD shows effectiveness in controlling seizures in more than half of SRSE patients, it can be a treatment option for SRSE. Currently, KD treatment for SRSE is based on personal experience and observational evidence has been published. In the context of a lack of a validated guideline, we convened a multicenter expert panel within the China Association Against Epilepsy (CAAE) Ketogenic Diet Commission to work out the Chinese expert recommendations on KD for SRSE. We summarize and discuss the latest clinical practice of KD for SRSE in critical care settings. Recommendations are given on patient selection, the timing of KD, diet implementation, and follow-up. More research data are needed in this area to support better clinical practice.
A minmax principle for nonlinear eigenproblems depending continuously on the eigenparameter

H. Voss

DOI: https://doi.org/10.1002/nla.670

2009-11-01

Numerical Linear Algebra with Applications

Abstract:Variational characterizations of real eigenvalues of selfadjoint operators on a Hilbert space depending nonlinearly on an eigenparameter usually assume differentiable dependence of the operator on the eigenparameter. In this paper we generalize these results to nonlinear problems that depend only continuously on the parameter. This result is applied to a class of variational eigenvalue problems that in particular contains the vibrations of plates with attached masses. Copyright © 2009 John Wiley & Sons, Ltd.
The Ketogenic Diet for Paediatric Patients with Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome

Wang Xinhua,Gao Xuan,Lu Guoping,Lu Zhongying,Zhou Shuizhen,Wang Yi,Zhou Yuanfeng

DOI: https://doi.org/10.1186/s42494-020-00013-1

2020-01-01

Acta Epileptologica

Abstract:Objective To investigate the effect and safety of ketogenic diet (KD) for the treatment of paediatric patients with super-refractory status epilepticus (SRSE) in febrile infection-related epilepsy syndrome (FIRES). Method From January 1, 2015 to October 31, 2017, ten critically ill paediatric patients with SRSE in FIRES were included in this study and treated with KD. The treatment effects of KD were evaluated by using continuous encephalography (CEEG) and amplitude-integrated electro-encephalography (aEEG). Results All 10 patients fulfilled the diagnostic criteria of SRSE in FIRES and achieved ketosis within 24–72 h following the administration of KD. CEEG and aEEG were monitored for several weeks to assess the efficacy of KD on status epilepticus (SE). SE was contained in 8 patients within 2 to 19 days after initiation of KD, and KD was discontinued in the other 2 patients. One of the 10 patients demonstrated severe adverse effects. Conclusion KD may be an alternative and safe treatment option in critical paediatric patients with SRSE in FIRES.
Ni-Mo Nanocatalysts on N-Doped Graphite Nanotubes for Highly Efficient Electrochemical Hydrogen Evolution in Acid.

Teng Wang,Yanru Guo,Zhenxing Zhou,Xinghua Chang,Jie Zheng,Xingguo Li

DOI: https://doi.org/10.1021/ACSNANO.6B06259

IF: 17.1

2016-10-24

ACS Nano

Abstract:Developing noble-metal-free catalysts for electrochemical hydrogen evolution reactions (HER) with superior stability in acid is of critical importance for large-scale, low-cost hydrogen production from water electrolysis. Herein, we report a highly efficient and stable noble-metal-free HER catalyst, which is composed of Ni and Mo2C nanocrystals supported on N-doped graphite nanotubes. This catalyst shows very low overpotential (65 mV in 0.5 M H2SO4 at a current density of 10 mA cm-2 with a Tafel plot of 67 mV/dec) and good stability for HER in acidic electrolyte, which is a promising noble-metal-free HER catalyst.
Ketogenic Diet for Children with Epilepsy: A Practical Meal Plan in a Hospital

Eunjoo Lee,Hoon-Chul Kang,Heung Dong Kim

DOI: https://doi.org/10.7762/cnr.2016.5.1.60

Abstract:A ketogenic diet (KD) is a dietary approach to treat intractable epilepsy. The KD begins with hospitalization and the child and their parents can adapt to the KD for 1-2 weeks. Recently, various type of dietary intervention such as the modified Atkins diet (MAD) and the low glycemic index treatment (LGIT) have been performed. Since 2010, we carried out the KD, MAD, and LGIT for total of 802 patients; 489 patients (61%) for the KD, 147 patients (18.3%) with the MAD, and 166 patients (20.7%) for the LGIT. In this report, application of these dietary practices in Severance Hospital is shared.
Ketogenic Diet in patients with refractory epilepsy

María J Rebollo G,Ximena Díaz Sm,Marcela Soto R,Johanna Pacheco A,Scarlet Witting E,Isidora Daroch R,Francisco Moraga M

DOI: https://doi.org/10.32641/rchped.vi91i5.1563

Abstract:Introduction: Epilepsy affects 0.5 to 1% of the population. 25% of pediatric patients have drug-resistant epilepsy (DRE). Ketogenic Diet (KD) emerges as an effective, non-pharmacological treatment in this group. Objective: To describe the effect of KD on seizure control and nutritional status in children whit DRE. Patients and method: We reviewed the medical records of patients with DRE treated with KD, between 2008 and 2018, evaluating age, diagnosis, number of seizures, number of antiepileptic drugs used, clinical outcomes, and complications. The KD was initiated in all patients hospitalized for a period no longer than seven days, who were evaluated for their nutritional and anthropometric sta tus, with weight and height measurements according to the clinical condition. Results: We analyzed 35 KD in 33 cases. The median age of KD initiation was 4.8 years with an interquartile range (IQR) of 2-3 to 6.8 years. Classical KD was used in 49% of patients, Modified Atkins Diet (MAD) in 37%, and Low-Glycemic Index Treatment (LGIT) in 14% of cases. The average duration was 13 months (SD 11 months). After three months of using KD, we observed at least 50% reduction of seizures in 82% (27/33) of the patients, out of these, 22.8% presented 90% or more reduction of seizures, and 20% ended up seizure-free. Adverse events were observed in 21 patients, mainly gastrointestinal (62%) and dyslipidemia (14%), without effect on height. All side effects resolved with medical ma nagement. Conclusions: KD is a useful treatment in pediatric patients with DRE without nutritional impact. The adverse events were easily controlled if the patients are evaluated by a multidisciplinary team, according to international guidelines.
Ketogenic Diets in the Treatment of Epilepsy

Maurizio Elia,Joerg Klepper,Baerbel Leiendecker,Hans Hartmann

DOI: https://doi.org/10.2174/1381612823666170809101517

Abstract:Background: Although a larger number of antiepileptic drugs became available in the last decades, epilepsy remains drug-resistant in approximately a third of patients. Ketogenic diet (KD), first proposed at the beginning of the last century, is complex and has anticonvulsant effects, yet not completely understood. Over the last decades, different types of ketogenic diets (KDs) have been developed, namely classical KD and modified Atkins diet (MAD). They offer an effective alternative for children and adults with drug-resistant epilepsies. Methods: We review several papers on KDs as an adjunctive treatment of refractory epilepsy of children and adults, discussing its efficacy and adverse events. Because of the heterogenous, uncontrolled nature of the studies, we analyzed all studies individually, without a meta-analysis. Results: KDs may be considered first choice treatment in some specific metabolic conditions, such as glucosetransporter type 1 and pyruvate dehydrogenase deficiencies, and mitochondrial complex I defects. Preliminary findings indicate that KDs may be specifically effective in some epileptic syndromes, such as West syndrome, severe myoclonic epilepsy of infancy, myoclonic-astatic epilepsy, febrile infection related epileptic syndrome, and drug-resistant idiopathic generalized epilepsies or refractory status epilepticus. Short term adverse events are usually mild in both children and adults, including gastrointestinal symptoms, hyperlipidemia, and hypercalciuria; potential long term adverse effects include nephrolitiasis, decreased bone density, and liver steatosis. Possible atherosclerotic effects remain a concern. Patients on KDs should be carefully monitored in specialized centers during initiation, maintenance and withdrawal periods, in order to minimize such adverse events, and to improve compliance. Although the majority of KD trials on children and adults with drug-resistant epilepsies are openlabel, uncontrolled studies based on small samples, an increasing number of randomized controlled trials have provided better quality evidence on its efficacy in recent years. Conclusion: There is a need for future randomized clinical trials aimed to confirm the efficacy of KDs in specific epileptic syndromes, and to provide further information about some practical unsolved problems, i.e. for how long KD treatment should be continued.
A Review of the Multi-Systemic Complications of a Ketogenic Diet in Children and Infants with Epilepsy

Kyra Newmaster,Zahra Zhu,Elizabeth Bolt,Christopher Day,Asmaa Mhanna,Sita Paudel,Osman Farooq,Arun Swaminathan,Prakrati Acharya,Wisit Cheungpasitporn,Siddharth Gupta,Debopam Samanta,Naeem Mahfooz,Gayatra Mainali,Sunil Naik,Ryan J. Chang,Paul R. Carney

DOI: https://doi.org/10.3390/children9091372

2022-09-10

Children

Abstract:Ketogenic diets (KDs) are highly effective in the treatment of epilepsy. However, numerous complications have been reported. During the initiation phase of the diet, common side effects include vomiting, hypoglycemia, metabolic acidosis and refusal of the diet. While on the diet, the side effects involve the following systems: gastrointestinal, hepatic, cardiovascular, renal, dermatological, hematologic and bone. Many of the common side effects can be tackled easily with careful monitoring including blood counts, liver enzymes, renal function tests, urinalysis, vitamin levels, mineral levels, lipid profiles, and serum carnitine levels. Some rare and serious side effects reported in the literature include pancreatitis, protein-losing enteropathy, prolonged QT interval, cardiomyopathy and changes in the basal ganglia. These serious complications may need more advanced work-up and immediate cessation of the diet. With appropriate monitoring and close follow-up to minimize adverse effects, KDs can be effective for patients with intractable epilepsy.

pediatrics
Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned

Iwona Maria Zarnowska

DOI: https://doi.org/10.3390/nu12092616

IF: 5.9

2020-08-27

Nutrients

Abstract:Ketogenic diet (KD) has been used to treat epilepsy for 100 years. It is a high-fat, low-carbohydrate, and sufficient-protein-for-growth diet that mimics the metabolic changes occurring during starvation. Except for classic KD, its modified counterparts, including modified Atkins diet and low-glycemic-index treatment, have gained grounds to increase palatability and adherence. Strong evidence exists that the KD offers protection against seizures in difficult-to-treat epilepsy and possesses long-lasting anti-epileptic activity, improving long-term disease outcome. The KD can also provide symptomatic and disease-modifying activity in a wide range of neurodegenerative diseases. In an era of highly available new anti-seizure medications (ASMs), the challenge of refractory epilepsy has still not been solved. This metabolic therapy is increasingly considered due to unique mechanisms and turns out to be a powerful tool in the hands of a skillful team. Despite decades of extensive research to explain the mechanism of its efficacy, the precise mechanism of action is to date still largely unknown. The key feature of this successful diet is the fact that energy is derived largely from fat but not from carbohydrates. Consequently, fundamental change occurs regarding the method of energy production that causes alterations in numerous biochemical pathways, thus restoring energetic and metabolic homeostasis of the brain. There are barriers during the use of this special and individualized therapy in many clinical settings worldwide. The aim of this review is to revisit the current state of the art of therapeutic application of KD in refractory epilepsy.

nutrition & dietetics
Outcomes of parenteral vs enteral ketogenic diet in pediatric super-refractory status epilepticus

Sirinuch Chomtho,Jaraspong Uaariyapanichkul,Krisnachai Chomtho

DOI: https://doi.org/10.1016/j.seizure.2022.01.019

IF: 3.414

Seizure

Abstract:Background: Super-refractory status epilepticus (SRSE) is extremely difficult to control and associated with poor outcomes. Ketogenic diet (KD) has been increasingly used for SRSE treatment. Enteral ketosis induction in SRSE is sometimes unfeasible, leading to the use of parenteral KD which has limited data among children. Objectives: To assess the effectiveness of KD and compare parenteral and enteral ketosis induction as treatment options in pediatric SRSE patients. Methods: This study is a retrospective medical record review of children < 15 years old diagnosed with SRSE who received KD as one of the treatment modalities during 2007-2021 at King Chulalongkorn Memorial Hospital, Thailand. Results: KD was used in 14 (77.8%) of the 18 pediatric SRSE cases whose age ranged from 2 months to 13.5 years. The leading etiologies of SRSE were immune-mediated encephalitis, infectious encephalitis, and epilepsy. Ketosis was induced via enteral route (kEN) in 8/14 and parenteral route (kPN) in 6/14 cases. The median time from the onset of SRSE to KD initiation was 6 days (IQR 4.8-9.3) with no demonstrable difference between groups. The median time to achieve significant ketosis was significantly shorter in the kPN (2 days; IQR 1.8-4) compared to the kEN group (5 days (3.3-7.8)). Nonetheless, the median time after ketosis induction to SRSE termination when anesthetic infusion was stopped was not statistically difference between the kPN (14 days; IQR 8.5-18) and the kEN group (10.5 days (5.5-15.3)). Hypertriglyceridemia was found more in the kPN (6/6, 100%) compared to the kEN group (3/8, 37.5%). All survivors (12/14) were seizure free at discharge. Conclusion: Parenteral ketosis induction achieved the target ketosis quicker than enteral induction but showed no difference in efficacy and duration for SRSE termination in our study. The adverse effects were minimal and controllable. Both parenteral and enteral KD could be considered early during SRSE treatment.
The Ketogenic Diet for the Treatment of Epilepsy: A Challenge for Nutritional Neuroscientists

Carl E. Stafstrom,Kristopher J. Bough

DOI: https://doi.org/10.1080/1028415031000084427

2003-01-01

Nutritional Neuroscience

Abstract:The ketogenic diet (KD) is a high-fat, low-carbohydrate, adequate-protein diet that has been used for more than eight decades for the treatment of refractory epilepsy in children. Despite this long history, the mechanisms by which the KD exerts its anti-seizure action are not fully understood. Questions remain regarding several aspects of KD action, including its effects on brain biochemistry and energetics, neuronal membrane function and cellular network behavior. With the explosion of the KD use in the last 10 years, it is now imperative that we understand these factors in greater detail, in order to optimize the formulation, administration and fine-tuning of the diet. This review discusses what is known and what remains to be learned about the KD, with emphasis on clinical questions that can be approached in the laboratory. We encourage scientists with a primary interest in nutritional neuroscience to join with those of us in the epilepsy research community to address these urgent questions, for the benefit of children ravaged by intractable seizures.

neurosciences,nutrition & dietetics
Ketogenic diet in childhood epilepsy: clinical algorithm in a tertiary care center

Sanaa Shaaban,Mohammed Al-Beltagi,Omnia El Rashidy,May Nassar,Yasmin El Gendy

DOI: https://doi.org/10.3389/fped.2023.1221781

2023-07-06

Abstract:Background: Dietary therapies play a crucial role in managing patients, especially those who have specific types of epilepsy, display adverse effects, or are not responding to pharmacological treatments. The ketogenic diet (KD) is a high-fat, restricted carbohydrate, and adequate protein regimen. The KD has proven to be an effective nonpharmacological treatment for drug-resistant epilepsy (DRE) by generating ketones that act as an alternative fuel source for the brain, thereby reducing the occurrence of seizures. The advantages of KD have been attributed to its universal availability, numerous administration techniques, and affordability. Objective: This article presents the KD algorithm developed by a multidisciplinary team of experts at the Children's Hospital, Ain Shams University, Egypt. The algorithm serves as a guide for implementing the KD in the treatment of DRE in children. The algorithm has been previously validated through a study. Methods: The algorithm consists of seven essential stages: (1) referral of patients to the Complex Epilepsy Committee, (2) pre-diet assessment of patients, (3) referral of patients to the Clinical Nutrition (CN) team, (4) diet selection and initiation, (5) seizure follow-up and diet fine-tuning, (6) diet reassessment after 3 months, and (7) evaluation of the KD journey after 24 months. Results: The KD algorithm was systematically developed and proved highly influential in facilitating the implementation of the KD. The algorithm yielded significant health benefits in pediatric patients. Conclusion: The KD algorithm provides a systematic approach to implementing the ketogenic diet and has demonstrated positive health outcomes in pediatric patients.
Binocular interactions and spatial disparity sensitivity in the superior colliculus of the siamese cat

B. Bacon,F. Lepore,J. Guillemot

DOI: https://doi.org/10.1007/s002210050613

Experimental Brain Research

Abstract:
Liver function profiles and their interpretation.

S. Rosalki,J. Dooley

British Journal of Hospital Medicine

Abstract:Plasma bilirubin, protein and enzyme measurements are used to evaluate hepatocellular function and integrity and bile duct patency. This 'liver function test' package is of value for the detection, confirmation, categorization and assessment of liver disease.
The Efficacy of a Ketogenic Diet in a Case With Febrile Infection-Related Epilepsy Syndrome in the Chronic Phase: A Case Report

Shota Yoneno,Shimpei Baba,Noriko Sumitomo,Kayoko Miyamoto,Kan Takahashi,Yuko Shimizu-Motohashi,Takashi Saito,Hirofumi Komaki

DOI: https://doi.org/10.7759/cureus.64149

2024-07-09

Cureus

Abstract:Although the treatment strategy for febrile infection-related epilepsy syndrome (FIRES) is improving, current research focuses on acute management. Evidence for the management of the chronic phase is limited. We present the case of a 19-year-old woman with FIRES who showed excellent response to a ketogenic diet (KD) administered in the chronic phase. At the age of four years, she presented with new-onset super-refractory status epilepticus after a febrile episode. She was diagnosed with FIRES and had profound motor and cognitive deterioration and drug-resistant epilepsy. From the age of 17, she experienced numerous seizures that often led to status epilepticus with respiratory failure, necessitating laryngotracheal separation and nocturnal mechanical ventilation. To improve seizure control, we planned a KD for the first time 15 years after the onset of FIRES. We introduced a classic KD (ketogenic ratio, 3:1) using blended meals through gastrotomy. Two months after starting the KD, she experienced a decrease in seizure frequency and duration. Moreover, as unexpected stabilization of respiration was achieved, mechanical ventilation was stopped. Our case implies that KD may be a promising treatment option for patients with FIRES in the chronic phase, as is believed to be the case in the acute phase.
Ketogenic Diet in the Treatment of Epilepsy

Kinga Borowicz-Reutt,Marlena Krawczyk,Julia Czernia

DOI: https://doi.org/10.3390/nu16091258

IF: 5.9

2024-04-25

Nutrients

Abstract:Epilepsy is one of the most disabling neurological diseases. Despite proper pharmacotherapy and the availability of 2nd and 3rd generation antiepileptic drugs, deep brain stimulation, and surgery, up to 30–40% of epilepsy patients remain drug-resistant. Consequences of this phenomenon include not only decreased a quality of life, and cognitive, behavioral, and personal disorders, but also an increased risk of death, i.e., in the mechanism of sudden unexpected death in epilepsy patients (SUDEP). The main goals of epilepsy treatment include three basic issues: achieving the best possible seizure control, avoiding the undesired effects of treatment, and maintaining/improving the quality of patients' lives. Therefore, numerous attempts are made to offer alternative treatments for drug-resistant seizures, an example of which is the ketogenic diet. It is a long-known but rarely used dietary therapy for intractable seizures. One of the reasons for this is the unpalatability of the classic ketogenic diet, which reduces patient compliance and adherence rates. However, its antiseizure effects are often considered to be worth the effort. Until recently, the diet was considered the last-resort treatment. Currently, it is believed that a ketogenic diet should be used much earlier in patients with well-defined indications. In correctly qualified patients, seizure activity may be reduced by over 90% or even abolished for long periods after the diet is stopped. A ketogenic diet can be used in all age groups, although most of the available literature addresses pediatric epilepsy. In this article, we focus on the mechanisms of action, effectiveness, and adverse effects of different variants of the ketogenic diet, including its classic version, a medium-chain triglyceride diet, a modified Atkins diet, and a low glycemic index treatment.

nutrition & dietetics
The ketogenic diet in patients with myoclonic status in non-progressive encephalopathy

Roberto Caraballo,Francesca Darra,Gabriela Reyes,Marisa Armeno,Araceli Cresta,Graciela Mestre,Bernardo Dalla Bernardina

DOI: https://doi.org/10.1016/j.seizure.2017.07.002

IF: 3.414

Seizure

Abstract:Myoclonic status in non-progressive encephalopathy (MSNPE) is characterized by the recurrence of long-lasting atypical status epilepticus associated with attention impairment and continuous polymorphous jerks, mixed with other complex abnormal movements, in infants suffering from a non-progressive encephalopathy. The ketogenic diet (KD) has been used as an alternative to antiepileptic drugs (AEDs) for patients with refractory epileptic encephalopathies. Purpose: In this study we assess the efficacy and tolerability of the KD in patients with MSNPE. Methods: Between March 1, 1980 and August 31, 2013, 99 patients who met the diagnostic criteria of MSNPE were seen (58 patients in Verona and 41 patients in Buenos Aires). Six of these 99 patients were placed on the KD using the Hopkins protocol and followed for a minimum period of 24 months. Results: Twelve months after initiating the diet, three patients had a 75%-99% decrease in seizures, two had a 50%-74% decrease in seizures, and the remaining child had a less than 50% seizure reduction. In five patients with a seizure reduction of more than 50%, the myoclonic status epilepticus disappeared within 6 months after starting the diet. All patients had very good tolerability and no adverse events were identified. In most of the patients AEDs were reduced. Conclusion: The KD is a promising therapy for MSNPE, with most of our patients showing a more than 50% seizure reduction. In patients that responded well to the diet cognitive performance and quality of life also improved.

AXENIC CULTURE OF TETRATRICHOMONAS GALLINARUM: GROWTH AND ANAEROBIC UTILIZATION OF CARBOHYDRATES AND RELATED COMPOUNDS.

Ketogenic Dietary Therapy in Adult Status Epilepticus: Current Progress and Clinical Application

The ketogenic diet for super-refractory status epilepticus patients in intensive care units

Implementation Concerns of Scholar-Practitioners: A Pilot Study of the Link between Research and Practice

Chinese expert recommendations on ketogenic diet therapy for super-refractory status epilepticus

A minmax principle for nonlinear eigenproblems depending continuously on the eigenparameter

The Ketogenic Diet for Paediatric Patients with Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome

Ni-Mo Nanocatalysts on N-Doped Graphite Nanotubes for Highly Efficient Electrochemical Hydrogen Evolution in Acid.

Ketogenic Diet for Children with Epilepsy: A Practical Meal Plan in a Hospital

Ketogenic Diet in patients with refractory epilepsy

Ketogenic Diets in the Treatment of Epilepsy

A Review of the Multi-Systemic Complications of a Ketogenic Diet in Children and Infants with Epilepsy

Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned

Outcomes of parenteral vs enteral ketogenic diet in pediatric super-refractory status epilepticus

The Ketogenic Diet for the Treatment of Epilepsy: A Challenge for Nutritional Neuroscientists

Ketogenic diet in childhood epilepsy: clinical algorithm in a tertiary care center

Binocular interactions and spatial disparity sensitivity in the superior colliculus of the siamese cat

Liver function profiles and their interpretation.

The Efficacy of a Ketogenic Diet in a Case With Febrile Infection-Related Epilepsy Syndrome in the Chronic Phase: A Case Report

Ketogenic Diet in the Treatment of Epilepsy

The ketogenic diet in patients with myoclonic status in non-progressive encephalopathy